Cancer gene therapy firm close to clinical trail after raising £1.3 million

A SCOTTISH pharmaceutical company behind a cancer gene therapy believed to have the potential to make chemotherapy four times more effective has secured £1.3 million of new funding.

To read the fuill story please click HERE.